Reeling from a tough stretch, Endo International has inked a deal to put 1,300 testosterone drug liability lawsuits to rest. The company disclosed a "master settlement agreement" on Tuesday to resolve ...
Endo ($ENDP) hasn't quite wrapped up its $8 billion deal for generics maker Par Pharmaceutical, recently agreeing to a loan package to speed things along. Now, the ...
In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1 billion in criminal penalties and another $450 million in criminal forfeiture ...
Mallinckrodt and Endo said they will merge through a $6.7 billion cash and stock deal creating a combined company that will be intent on bouncing back from their troubled recent histories, stemming ...
Planta, Vol. 212, No. 3 (February 2001), pp. 348-358 (11 pages) Korrigan (kor) is a dwarf mutant of Arabidopsis thaliana (L.) Heynh. that is deficient in a membrane-bound endo-1,4-β-glucanase. The ...
Endo Health Solutions said today it is acquiring Canadian-based specialty pharma company Paladin Labs for roughly $1.6 billion, in a stock and cash deal that expands the buyer’s global presence, ...
US healthcare company Endo Health Solutions has acquired Canada-based specialty pharma company Paladin Labs in a deal worth up to US $1.6 billion. Paladin Labs focuses on acquiring or in-licensing ...
Carol A. Loopstra, Aidyn Mouradov, Adam Vivian-Smith, Tina V. Glassick, Beth V. Gale, Simon G. Southerton, Heidi Marshall, Robert D. Teasdale Plant Physiology, Vol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback